Beyond Air Inc (XAIR): Enterprise Value to EBITDA Ratio
Beyond Air, Inc. (XAIR) is implementing AI modules for device management and automating patient tracking. The company is expanding its presence in US clinics by promoting the LungFit system for therapeutic gas generation. This EV/EBITDA chart, with a value of 0.00, complements the business analysis. The brand's ecosystem replaces bulky cylinders with autonomous devices, creating a safe environment for the therapy of severe lung infections.
Comprehensive metric breakdowns and analytics for beyondair.net (XAIR)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
- financial results and valuation multiples details:
XAIR - Net Financial Result|Projected Future Earnings Beyond Air, Inc.|XAIR - Price to Earnings Ratio|Forward P/E Multiple Beyond Air|XAIR - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization XAIR|XAIR - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Beyond Air|XAIR - Earnings per share for the trailing year|Quarterly EPS earnings growth beyondair.net|XAIR - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Beyond Air, Inc.
Analysis of all company metrics:AINostix XAIR
This ratio compares the total enterprise value, including net debt, to operating profit before taxes and amortization, allowing for an assessment of the real value of assets relative to their yield. For Beyond Air, Inc. (XAIR), which is developing innovative nitric oxide therapy, the EV/EBITDA multiple reflects the balance between capital expenditures for expansion and the efficiency of its medical solutions, signaling the company's degree of leverage to the investor.
Competitor analysis
Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (CONMED Corp.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Medical (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode Ltd.)|PMI (picardmedical.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Corp - EV/EBITDA Multiple|Company Value to EBITDA Tactile Systems Technology|SNWV: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation OM|ELMD (SmartVest) - EV/EBITDA Multiple|LENSAR Inc. (LNSR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RCEL|Enterprise Value to EBITDA Ratio profoundmedical.com PROF|EV/EBITDA Multiple BDMD (Baird Medical)|EV/EBITDA Multiple EDAP TMS SA EDAP|APYX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ICCM: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG (pulmonx.com) - Enterprise Value to EBITDA Ratio|TELA Bio - Business Value to Operating Income Before Depreciation|CTSO (CytoSorbents Corp) - EV/EBITDA Multiple|Company Value to EBITDA sensushealthcare.com SRTS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zynex (ZYXI)|electrocore.com (ECOR) - Enterprise Value to EBITDA Multiple|Vicarious Surgical - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Inspira Technologies Oxy B.H.N. Ltd. IINN|SeaStar Medical Holding - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio IRIDEX Corporation IRIX|ibs.inc (INBS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa Inc.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STRATA Skin Sciences Inc.|Enterprise Value to EBITDA Ratio GlucoTrack Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BSGM: EV/EBITDA Multiple|CUTR (cutera.com) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|KNW (Know Labs) - EV/EBITDA Multiple|Company Value to EBITDA Inari Medical Inc NARI|Enterprise Value to EBITDA Ratio NVRO (Nevro Corporation)|RSLS - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Silk Road Medical, Inc SILK
